Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tero Hallikainen

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Duodecim; Laaketieteellinen Aikakauskirja|October 3, 2015
[Managing aggression and violence associated with psychosis]Tero Hallikainen, Eila Repo-Tiihonen
Duodecim; Laaketieteellinen Aikakauskirja|March 5, 2016
[Antisocial personality disorder]Eila Repo-Tiihonen, Tero Hallikainen
Neuropsychobiology|May 5, 2005
Effects of venlafaxine treatment on clozapine plasma levels in schizophrenic patientsEila Repo-Tiihonen, Anne Eloranta, Tero Hallikainen, et al.
Mental Illness|December 6, 2014
Antipsychotic Polypharmacy in Clozapine Resistant Schizophrenia: A Randomized Controlled Trial of Tapering Antipsychotic Co-treatmentEila Repo-Tiihonen, Tero Hallikainen, Päivi Kivistö, et al.
The Journal of Mental Health Policy and Economics|November 26, 2011
Costs of intensive psychiatric care for treatment-resistant minorsTarja Paakkonen, Jari Tiihonen, Heikki Paakkonen, et al.
American Journal of Medical Genetics. Part A|May 16, 2003
Ethanol consumption and DRD2 gene TaqI a polymorphism among socially drinking malesTero Hallikainen, J Hietala, J Kauhanen, et al.
Biological Psychiatry|December 4, 2003
Lamotrigine in treatment-resistant schizophrenia: a randomized placebo-controlled crossover trialJari Tiihonen, Tero Hallikainen, Olli-Pekka Ryynänen, et al.
Psychiatry Research|April 3, 2002
Analysis of monoamine oxidase A (MAOA) promoter polymorphism in Finnish male alcoholicsTakuya Saito, Herbert M Lachman, Libna Diaz, et al.
The Journal of Clinical Psychiatry|August 10, 2005
Topiramate add-on in treatment-resistant schizophrenia: a randomized, double-blind, placebo-controlled, crossover trialJari Tiihonen, Pirjo Halonen, Kristian Wahlbeck, et al.
American Journal of Human Genetics|August 7, 2012
Exome sequencing followed by large-scale genotyping suggests a limited role for moderately rare risk factors of strong effect in schizophreniaAnna C Need, Joseph P McEvoy, Massimo Gennarelli, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Duodecim; Laaketieteellinen Aikakauskirja|October 3, 2015
[Managing aggression and violence associated with psychosis]Tero Hallikainen, Eila Repo-Tiihonen
Duodecim; Laaketieteellinen Aikakauskirja|March 5, 2016
[Antisocial personality disorder]Eila Repo-Tiihonen, Tero Hallikainen
Neuropsychobiology|May 5, 2005
Effects of venlafaxine treatment on clozapine plasma levels in schizophrenic patientsEila Repo-Tiihonen, Anne Eloranta, Tero Hallikainen, et al.
Mental Illness|December 6, 2014
Antipsychotic Polypharmacy in Clozapine Resistant Schizophrenia: A Randomized Controlled Trial of Tapering Antipsychotic Co-treatmentEila Repo-Tiihonen, Tero Hallikainen, Päivi Kivistö, et al.
The Journal of Mental Health Policy and Economics|November 26, 2011
Costs of intensive psychiatric care for treatment-resistant minorsTarja Paakkonen, Jari Tiihonen, Heikki Paakkonen, et al.
American Journal of Medical Genetics. Part A|May 16, 2003
Ethanol consumption and DRD2 gene TaqI a polymorphism among socially drinking malesTero Hallikainen, J Hietala, J Kauhanen, et al.
Biological Psychiatry|December 4, 2003
Lamotrigine in treatment-resistant schizophrenia: a randomized placebo-controlled crossover trialJari Tiihonen, Tero Hallikainen, Olli-Pekka Ryynänen, et al.
Psychiatry Research|April 3, 2002
Analysis of monoamine oxidase A (MAOA) promoter polymorphism in Finnish male alcoholicsTakuya Saito, Herbert M Lachman, Libna Diaz, et al.
The Journal of Clinical Psychiatry|August 10, 2005
Topiramate add-on in treatment-resistant schizophrenia: a randomized, double-blind, placebo-controlled, crossover trialJari Tiihonen, Pirjo Halonen, Kristian Wahlbeck, et al.
American Journal of Human Genetics|August 7, 2012
Exome sequencing followed by large-scale genotyping suggests a limited role for moderately rare risk factors of strong effect in schizophreniaAnna C Need, Joseph P McEvoy, Massimo Gennarelli, et al.
Pageof 2